Decision expected on use of SGLT1/SGLT2 inhibitors in combination with insulin therapy.
Read moreThe IDF North America and Caribbean (NAC) Region includes 29 countries and territorities, currently representing 24 diabetes organisations in 23 countries.
According to the IDF Diabetes Atlas 8th Edition, an estimated 45.9 million adults aged 20-29 years were living with diabetes in the IDF NAC region in 2017, representing a regional prevalence of 13%, the highest of all IDF regions. Over one-third (37.6%) of adults living with diabetes are undiagnosed. The vast majority (83.2%) of adults with diabetes in the region live in urban areas.
The elected IDF representatives for the North America and Caribbean Region for 2018-19 are:
Chair: Ms Glynis Alonzo Beaton, Guyana
Chair Elect: Mr Timotheus Dorh, St Lucia
Decision expected on use of SGLT1/SGLT2 inhibitors in combination with insulin therapy.
Leaders in type 1 diabetes research and treatment teach students who live with diabetes.
